However, overexpression of APP results in not only increased production of both Aβ40 and Aβ42, the two most common peptides associated with AD pathogenesis, but also elevated levels of other APP fragments which can have neuroprotective, neurotoxic, or signaling functions that may complicate the interpretation of the results37. The gene discussed is APP; the disease is Alzheimer disease.